Cargando…
The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
BACKGROUND: Detecting a new effective and hypotoxic anticancer drug is an emerging new strategy for cancer chemotherapy. Doxycycline (DC) is a kind of antibiotics but also inhibits tumorigenesis. METHODS: MTT and cell invasion assay, flow cytometry, western-blot analysis and nude mice were used to i...
Autores principales: | Wu, Wei, Yu, Li-hua, Ma, Bei, Xu, Ming-juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943859/ https://www.ncbi.nlm.nih.gov/pubmed/24598933 http://dx.doi.org/10.1371/journal.pone.0089841 |
Ejemplares similares
-
Retraction: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2020) -
lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018) -
Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019) -
Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to Cisplatin
por: Yang, Fan, et al.
Publicado: (2015) -
Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
por: Guo, Jianfeng, et al.
Publicado: (2021)